LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,573,000 | -4.1% | 99,562 | -0.7% | 3.85% | -7.4% |
| Q2 2022 | $8,944,000 | +7.9% | 100,244 | +36.0% | 4.16% | +21.0% |
| Q1 2022 | $8,291,000 | -74.4% | 73,700 | -77.4% | 3.44% | -86.1% |
| Q4 2020 | $32,431,000 | +5.8% | 326,100 | +1.4% | 24.83% | -22.1% |
| Q3 2020 | $30,645,000 | +196.5% | 321,500 | +247.9% | 31.88% | +59.2% |
| Q2 2020 | $10,336,000 | -11.7% | 92,407 | -42.6% | 20.02% | +61.8% |
| Q1 2020 | $11,702,000 | +292.3% | 160,919 | +437.0% | 12.38% | +327.5% |
| Q3 2019 | $2,983,000 | -84.4% | 29,965 | -82.1% | 2.90% | -78.0% |
| Q2 2019 | $19,119,000 | +1.4% | 167,487 | +11.7% | 13.16% | +21.4% |
| Q1 2019 | $18,857,000 | – | 150,000 | – | 10.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |